Literature DB >> 6134037

The molecular basis for the clinical diversity of beta thalassaemia in Cypriots.

J S Wainscoat, J M Old, D J Weatherall, S H Orkin.   

Abstract

Much of the clinical variability in the course of homozygous beta thalassaemia in the Cypriot population can be accounted for by the interaction of alpha thalassaemia and by the existence of different molecular forms of beta thalassaemia. Most severe forms of the disorder result from the homozygous state for the common Mediterranean type of beta thalassaemia. One particularly mild form of beta thalassaemia, which also occurs in other Mediterranean populations, results from a single base change at position 6 in the first intervening sequence of the beta-globin gene. These observations provide a basis for the development of a programme for first-trimester antenatal diagnosis using oligonucleotide probes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134037     DOI: 10.1016/s0140-6736(83)92694-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  The molecular basis of beta-thalassemia in Turkey.

Authors:  A N Başak; H Ozçelik; A Ozer; A Tolun; M Aksoy; L Ağaoğlu; F Ridolfi; L Ulukutlu; N Akar; A Gürgey
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

2.  Beta-thalassaemia: molecular pathogenesis and clinical variability.

Authors:  A E Kulozik
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

3.  Effect of alpha thalassaemia trait and enhanced gamma chain production on disease severity in beta thalassaemia major and intermedia.

Authors:  P Gringras; B Wonke; J Old; A Fitches; D Valler; A M Kuan; V Hoffbrand
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

Review 4.  Prenatal diagnosis of the common haemoglobin disorders.

Authors:  D J Weatherall; J M Old; S L Thein; J S Wainscoat; J B Clegg
Journal:  J Med Genet       Date:  1985-12       Impact factor: 6.318

5.  Identification of a beta-thalassemia mutation associated with a novel haplotype of RFLPs.

Authors:  G F Atweh; B G Forget
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

6.  Prenatal diagnosis of beta thalassaemia by oligonucleotide analysis in Mediterranean populations.

Authors:  M C Rosatelli; T Tuveri; M T Scalas; A Di Tucci; G B Leoni; M Furbetta; G Monni; A Cao
Journal:  J Med Genet       Date:  1988-11       Impact factor: 6.318

7.  DNA haplotype distribution in Algerian beta thalassaemia patients. An extended evaluation by family studies and representative molecular characterization.

Authors:  F Rouabhi; C Lapouméroulie; S Amselem; R Krishnamoorthy; L Adjrad; R Girot; P Chardin; M Benabdji; D Labie; C Beldjord
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

8.  Determination of the spectrum of beta-thalassemia genes in Spain by use of dot-blot analysis of amplified beta-globin DNA.

Authors:  S Amselem; V Nunes; M Vidaud; X Estivill; C Wong; L d'Auriol; D Vidaud; F Galibert; M Baiget; M Goossens
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

9.  Clinical and haematological evaluation of beta thalassaemia intermedia characterised by unusually low Hb F and increased Hb A2: beta thalassaemia intermedia II.

Authors:  A Gurgey; S Kayin; E Kansu; C Altay
Journal:  J Med Genet       Date:  1985-06       Impact factor: 6.318

Review 10.  Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants.

Authors:  J Flint; R M Harding; J B Clegg; A J Boyce
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.